Cargando…
A comparison of outcomes for patients with intermediate and high risk prostate cancer treated with low dose rate and high dose rate brachytherapy in combination with external beam radiotherapy
INTRODUCTION: There is evidence to support use of external beam radiotherapy (EBRT) in combination with both low dose rate brachytherapy (LDR–EBRT) and high dose rate brachytherapy (HDR–EBRT) to treat intermediate and high risk prostate cancer. METHODS: Men with intermediate and high risk prostate c...
Autores principales: | Slevin, Finbar, Rodda, Sree Lakshmi, Bownes, Peter, Murray, Louise, Bottomley, David, Wilkinson, Clare, Adiotomre, Ese, Al-Qaisieh, Bashar, Dugdale, Emma, Hulson, Oliver, Mason, Joshua, Smith, Jonathan, Henry, Ann M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831705/ https://www.ncbi.nlm.nih.gov/pubmed/31701035 http://dx.doi.org/10.1016/j.ctro.2019.10.001 |
Ejemplares similares
-
Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’
por: Slevin, Finbar, et al.
Publicado: (2020) -
Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancer
por: Slevin, Finbar, et al.
Publicado: (2020) -
Ten-year longitudinal health-related quality of life following iodine-125 brachytherapy monotherapy for localized prostate cancer
por: Slevin, Finbar, et al.
Publicado: (2020) -
Importance of dynamic contrast enhanced magnetic resonance imaging for targeting biopsy and salvage treatments after prostate cancer recurrence
por: Mason, Josh, et al.
Publicado: (2018) -
Prevention of high-dose-rate brachytherapy accidents
por: Commission Internationale de Protection contre les Radiations
Publicado: (2005)